Display HSQ10180205

For more detailed information on a particular section refer to the help specific to that section.

Times presented in this website are for Queensland (without daylight saving).

Detailed Help (Clicking detailed help will open a new browser window)
GCSFs (granulocyte colony-stimulating factor); Grastims

Issued by Queensland Health Pharmaceuticals Category

Invitation to Offer

Status: Closed
Mega Category: General goods and services
Number: HSQ10180205
Released: Mon, 11 May 2020 at 12:00AM Brisbane, Queensland
Closed: Mon, 25 May 2020 at 2:00PM Brisbane, Queensland
UNSPSC: Drugs and Pharmaceutical Products - (100%)
Region/s: Cairns & Far North Queensland
Mount Isa & North West Region
The Central West
South West & Darling Downs
Mackay Whitsunday Region
Wide Bay Burnett
South East Queensland

Section 1

Tender Overview


21/05/2020 - SAMPLES; Our lead clinical evaluators have requested two samples along with digital images of labels, immediate container, shippers if applicable, for products not previously supplied to QH.

Electronic Signatures-  Exert from QH Legal Branch "Suppliers using electronic signatures to sign RFO/ITO’s response forms is acceptable. It is up to the supplier to facilitate amongst themselves how the authorised person will sign their offer response. They could simply print, sign and scan to email, to collate with the RFO response"

19/05/2020 - SAMPLES; if you have not previously supplied to Queensland Health, please send your Samples to; 

  • Robin Lee Assistant Director, 794 Boundary Road, Richlands, Queensland, 4077. Mark as  HSQ101802-05 Tender Samples immediately. 

14/05/2020 -  Uploading of the Industry Briefing Slide Show Pack.

12/05/2020 - Confirmation - Tenders will close on QTenders at 2:00pm on Monday 25th May 2020 .

  • RFO Pack (SOA HSQ101802-5  Request for Offer - GCSFs Grastims v13 12 May 2020)  has been updated to reflect the time , no other changes.

12/05/2020 - Industry Briefing - Will be delivered in the form of a Power Point Slide Pack, availlable for download at any time on QTenders. You will recieve a notification via QTeners once this is available - Target Wednesday 13th AM.




Offers are invited by Department of Health in this Request for Offer HSQ101802-05 for the establishment or variation of a Standing Offer Arrangement (SOA) Pharmaceutical Header Arrangement (PHA) for the provision of General Pharmaceuticals - GCSFs (granulocyte colony-stimulating factor); Grastims.

Offers are to be submitted on the basis that they conform with the following RFO Documentation:

·    PART ONE A – Offer Documentation for current SOA Pharma Header Arrangement Holders

o  Section A -            Request for Offer Details;

o  Section B -            Conditions of Offer;

o  Section C -            Specifications and Particulars;

o  Section D -            Response Forms;

·      PART TWO – Standing Offer Arrangement (SOA) Pharmaceutical Header Arrangement (PHA).

o  Attachment 1 -      Pricing Template

The Department currently has a state-wide Standing Offer Arrangement (SOA) Pharmaceutical Header Arrangement (PHA) for the provision of General Pharmaceuticals which covers multiple therapeutic groups, and products which are used throughout many areas within each Hospital Health Service. 

  • The existing SOA has an estimated spend of $460M (exc. GST) per annum across all therapeutic groups.
  • The awarded offeror will have the products added to the Schedule D list of products of the Standing Offer Arrangement (SOA) Pharmaceutical Header Arrangement (PHA).

Arrangement Commencement Date

15 June 2020

Arrangement Completion Date

31 December 2021

Arrangement Term


  Eighteen (18) months and sixteen (16) days.

Option Extension Period:

 2 x twelve (12) months option


The Offeror must deliver the Goods in compliance with the Mandatory Requirements, including:

  • Insurances (Public & Product (Goods) Liability and Workers Compensation);
  • Quality Assurance (QA) as per AS/NZS/ISO 9001:2015 and/or ISO 13485:2016, and/or TGA manufacturing licence and/or Wholesale Licence;
  • TGA certification for all products (where applicable);
  • Compliance to specification requirements; and
  • Offer and samples lodged in-full, on-time (within 5 business days of being requested)

Offerors will be encouraged to offer the following pricing;

  1.  Sole listing,
  2.  Multiple Contract Listing, with other molecules.


  • SOA HSQ101802-5 Request for Offer - GCSFs Grastims v13 (open and please keep track changes on)
  • SOA QH75162 PHS RFO Conditions of Offer final V 5 - This is the attached RFO conditions (definitions and interpretation)
  • RFO Pricing Template for GCSFs Grastims - This is the pricing template to submit your product details.
  • a copy of the Standing Offer Arrangement (SOA) Pharmaceutical Header Arrangement (PHA) for the provision of General Pharmaceuticals 


Clarifications due on the 14th of May

Samples; if not yet supplied please send to;

•             Robin Lee Assistant Director, 794 Boundary Road, Richlands, Queensland, 4077; Mark as Tender Samples Offer No HSQ101802-05


More about tendering here

Section 2

Still need help? Contact Us

Other Contacts
users Ammie Van Der Syde
Type Technical
email Pharmaceuticals-sps@health.qld.gov.au

Section 3

Here is the detail

If there are no documents listed in this section, please refer to Section 1 Tender Overview.

Documents can not be downloaded once Tender has closed.